Icahn School of Medicine at Mount Sinai: Post-Acute COVID-19 Syndrome trials
The registry lists 10 Post-Acute COVID-19 Syndrome studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 6 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 3Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Fareon Open Label Device Clinical TrialNot yet recruitingNCT07600320Not applicable
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID DysfunctionNot yet recruitingNCT07597902Phase 2
- Harnessing Optimism and Perseverance in the Face of Long COVID-EspañolNot yet recruitingNCT07216040Not applicable
- Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19RecruitingNCT06960928Phase 3
- Antiviral Clinical Trial for Long Covid-19RecruitingNCT06511063Phase 2
- Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue SyndromeRecruitingNCT06511050Phase 1/2
- Vagus Nerve Stimulation as Treatment for Long CovidCompletedNCT05608629Not applicableResults posted
- Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive DysfunctionCompletedNCT06739668Not applicable
- tVNS in Long COVID-19Active, not recruitingNCT06585254Not applicable
- VNS for Long-COVID-19CompletedNCT05630040Not applicable